AmWeb: a novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients

被引:11
作者
Ironmonger, Dean [1 ]
Edeghere, Obaghe [1 ]
Gossain, Savita [2 ]
Bains, Amardeep [1 ]
Hawkey, Peter M. [2 ,3 ]
机构
[1] Publ Hlth England, Reg Epidemiol Unit, Birmingham, W Midlands, England
[2] Heart England NHS Fdn Trust, Publ Hlth Lab, Publ Hlth England, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England
关键词
microbiology; health informatics; antibiotics; ANTIBIOTIC-RESISTANCE; WHONET;
D O I
10.1093/jac/dkt181
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Antimicrobial resistance (AMR) is recognized as one of the most significant threats to human health. Local and regional AMR surveillance enables the monitoring of temporal changes in susceptibility to antibiotics and can provide prescribing guidance to healthcare providers to improve patient management and help slow the spread of antibiotic resistance in the community. There is currently a paucity of routine community-level AMR surveillance information. Methods: The HPA in England sponsored the development of an AMR surveillance system (AmSurv) to collate local laboratory reports. In the West Midlands region of England, routine reporting of AMR data has been established via the AmSurv system from all diagnostic microbiology laboratories. The HPA Regional Epidemiology Unit developed a web-enabled database application (AmWeb) to provide microbiologists, pharmacists and other stakeholders with timely access to AMR data using user-configurable reporting tools. Results: AmWeb was launched in the West Midlands in January 2012 and is used by microbiologists and pharmacists to monitor resistance profiles, perform local benchmarking and compile data for infection control reports. AmWeb is now being rolled out to all English regions. Conclusions: It is expected that AmWeb will become a valuable tool for monitoring the threat from newly emerging or currently circulating resistant organisms and helping antibiotic prescribers to select the best treatment options for their patients.
引用
收藏
页码:2406 / 2413
页数:8
相关论文
共 31 条
[1]   BSAC standardized disc susceptibility testing method (version 10) [J].
Andrews, J. M. ;
Howe, R. A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (12) :2726-2757
[2]  
[Anonymous], WHO global strategy for futher reducing the leprosy burden and sustaining leprosy control activities, 2006-2011
[3]   Surveillance of antimicrobial resistance - what, how and whither? [J].
Bax, R ;
Bywater, R ;
Cornaglia, G ;
Goossens, H ;
Hunter, P ;
Isham, V ;
Jarlier, V ;
Jones, R ;
Phillips, I ;
Sahm, D ;
Senn, S ;
Struelens, M ;
Taylor, D ;
White, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (06) :316-325
[4]  
Centers for Disease Control and Prevention, ADDRESSING EMERGING
[5]  
Commission to the European Parliament and the Council, ACTION PLAN AGAINST
[6]  
European Centre for Disease Prevention and Control, ANNUAL REPORT OF THE
[7]  
European Centre for Disease Prevention and Control (ECDC) and European Medicines Agency (EMEA), TECHNICAL REPORT THE
[8]   The need for antimicrobial resistance surveillance [J].
Felmingham, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :1-7
[9]   A framework for global surveillance of antibiotic resistance [J].
Grundmann, Hajo ;
Klugman, Keith P. ;
Walsh, Timothy ;
Ramon-Pardo, Pilar ;
Sigauque, Betuel ;
Khan, Wasif ;
Laxminarayan, Ramanan ;
Heddini, Andreas ;
Stelling, John .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :79-87
[10]   Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis [J].
Gupta, K ;
Sahm, DF ;
Mayfield, D ;
Stamm, WE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) :89-94